Aims and Scope of International Journal of Hematology
International Journal of Hematology is the official journal of the Japanese Society of Hematology. Since 2008, it has been published by Springer Japan, but used to be published by Carden Jennings.
Key Metrics
CiteScore 

3.9
Impact Factor 

< 5
SJR 

Q2Hematology

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on International Journal of Hematology
International Journal of Hematology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGER JAPAN KK |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in International Journal of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in International Journal of Hematology
Clinical implications of minimal residual disease monitoring in multiple myeloma.
- 1 Jul 2026
- International journal of hematology
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.
- 1 Jul 2026
- International journal of hematology
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias.
- 1 Jul 2026
- International journal of hematology
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.
- 1 Jul 2026
- International journal of hematology
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan.
- 1 Jul 2026
- International journal of hematology
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction.
- 1 Jul 2026
- International journal of hematology
Clinical implications of minimal residual disease monitoring in multiple myeloma.
- 1 Jul 2026
- International journal of hematology
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.
- 1 Jul 2026
- International journal of hematology
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias.
- 1 Jul 2026
- International journal of hematology
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.
- 1 Jul 2026
- International journal of hematology
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan.
- 1 Jul 2026
- International journal of hematology
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction.
- 1 Jul 2026
- International journal of hematology